PRLD, operating in its industry as per available data, exhibits compliant debt levels but fails significantly on liquidity and interest income ratios, resulting in non-compliance across major Shariah standards. The high interest income ratio of 179.16% indicates substantial riba exposure, necessitating purification beyond 100% of dividends, effectively rendering dividends impermissible without restructuring. No non-permissible business activities are identified, and ESG factors show low risk with positive alignment to Islamic principles through ethical biotech focus. However, exclusion from all major Shariah indices confirms overall non-compliance. Investors should monitor financial improvements and consult scholars for personalized rulings.